Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors

[1]  S. Steinbacher,et al.  Dipeptidyl nitrile inhibitors of Cathepsin L. , 2009, Bioorganic & medicinal chemistry letters.

[2]  R. Guy,et al.  Antimalarial activity of thiosemicarbazones and purine derived nitriles. , 2009, Bioorganic & medicinal chemistry letters.

[3]  K. Lee,et al.  Cathepsin B is a target of Hedgehog signaling in pancreatic cancer. , 2009, Cancer letters.

[4]  Michael C. Myers,et al.  Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype. , 2008, Bioorganic & medicinal chemistry letters.

[5]  A. Shelat,et al.  Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB. , 2008, Bioorganic & medicinal chemistry letters.

[6]  R. Ménard,et al.  Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors , 2008, Journal of enzyme inhibition and medicinal chemistry.

[7]  O. Vasiljeva,et al.  Emerging roles of cysteine cathepsins in disease and their potential as drug targets. , 2007, Current pharmaceutical design.

[8]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[9]  Ming Zhou,et al.  Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. , 2006, Bioorganic & medicinal chemistry letters.

[10]  Y. Ru,et al.  Azepanone-based inhibitors of human cathepsin L. , 2005, Journal of medicinal chemistry.

[11]  S. Diamond,et al.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Whelan,et al.  Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection , 2005, Science.

[13]  J. Kos,et al.  Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. , 2005, Experimental cell research.

[14]  E. Im,et al.  Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.

[15]  J. Gut,et al.  Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain. , 2005, Bioorganic & medicinal chemistry letters.

[16]  Bonnie F. Sloane,et al.  Cysteine cathepsins in human cancer , 2004, Biological chemistry.

[17]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[18]  D. Brömme,et al.  Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. , 2002, Chemical reviews.

[19]  E. Purisima,et al.  Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides. , 2002, Journal of medicinal chemistry.

[20]  C. Bryant,et al.  Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors. , 2002, Bioorganic & medicinal chemistry.

[21]  J. McKerrow,et al.  Synthesis and Structure−Activity Relationship Study of Potent Trypanocidal Thio Semicarbazone Inhibitors of the Trypanosomal Cysteine Protease Cruzain , 2002 .

[22]  D. Turk,et al.  Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.

[23]  S. Rafati,et al.  Identification of Leishmania major cysteine proteinases as targets of the immune response in humans. , 2001, Molecular and biochemical parasitology.

[24]  J. Falgueyret,et al.  Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. , 2001, Journal of medicinal chemistry.

[25]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[26]  Y. Fujisawa,et al.  Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption. , 1998, Journal of medicinal chemistry.

[27]  K. Tanaka,et al.  Purification and properties of a new cathepsin from rat liver. , 1978, Journal of biochemistry.

[28]  A. Angulo,et al.  Inhibitors of human cathepsin L and cruzain as therapeutic agents. , 2008 .

[29]  Michael C. Myers,et al.  Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor. , 2008, Bioorganic & medicinal chemistry letters.

[30]  Rogelio Siles.  Design, synthesis and biological evaluation of new anti-Cancer nitrogen-containing combretastatins and novel cysteine protease inhibitors for the treatment of Chagas. , 2005 .

[31]  N. Katunuma,et al.  Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. , 1990, Journal of enzyme inhibition.